ST
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer | Nature communications |  | 2026 | 36 | 14 | ||
| Neural anticipation of virtual infection triggers an immune response | Nature neuroscience | | 2025 | 49 | 37 | ||
| Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine : Immune Correlates in Long-Term Survivors | Biomedicines | | 2025 | 33 | 47 | ||
| Circulating innate lymphoid cells are dysregulated in patients with prostate cancer | Cellular & Molecular Biology Letters | | 2025 | 38 | 23 | ||
| Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor | Journal of leukocyte biology | | 2025 | 43 | 124 | ||
| Assessing the impact of persistent HIV infection on innate lymphoid cells using in vitro models | ImmunoHorizons | | 2023 | 148 | 195 | ||
| Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability | Frontiers in immunology | | 2023 | 119 | 85 | ||
| Dynamic single-cell regulomes characterize human peripheral blood innate lymphoid cell subpopulations | iScience | | 2023 | 162 | 60 | ||
| IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia | Haematologica | | 2023 | 122 | 85 | ||
| Dampening of cytotoxic innate lymphoid cells: A new tumour immune escape mechanism in B cell non-Hodgkin's lymphoma | Cellular immunology | | 2022 | 321 | 175 | ||
| Gliadin-reactive vitamin D-sensitive proinflammatory ILCPs are enriched in celiac patients | Cell reports | | 2022 | 249 | 239 | ||
| Development of human ILCs and impact of unconventional cytotoxic subsets in the pathophysiology of inflammatory diseases and cancer | Frontiers in immunology | | 2022 | 251 | 279 | ||
| c-Maf enforces cytokine production and promotes memory-like responses in mouse and human type 2 innate lymphoid cells | EMBO journal | | 2022 | 385 | 505 | ||
| Static adhesion assay for human peripheral blood mononuclear cells | Bio-protocol | | 2022 | 252 | 247 | ||
| PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions | Nature Communications | | 2021 | 359 | 288 | ||
| Healthy and patient type 2 innate lymphoid cells are differently affected by in vitro culture conditions | Journal of Asthma and Allergy | | 2021 | 248 | 91 | ||
| Severe COVID-19 patients exhibit an ILC2 NKG2D+ population in their impaired ILC compartment | Cellular & Molecular Immunology | | 2021 | 247 | 138 | ||
| Human primed ILCPs support endothelial activation through NF-κB signaling | eLife | | 2021 | 357 | 225 | ||
| Sharpening of peripersonal space during the COVID-19 pandemic | Current Biology | | 2021 | 242 | 265 | ||
| Distinct and shared gene expression for human innate versus adaptive helper lymphoid cells | Journal of Leukocyte Biology | | 2020 | 414 | 301 | ||
| Immunosuppressive mediators impair proinflammatory innate lymphoid cell function in human malignant melanoma | Cancer Immunology Research |  | 2020 | 630 | 4 | ||
| Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes | Cancers | | 2020 | 393 | 272 | ||
| The pro- and anti-tumor role of ILC2s | Seminars in Immunology | | 2019 | 354 | 0 | ||
| ILC2s: new actors in tumor immunity | Frontiers in Immunology | | 2019 | 418 | 237 | ||
| Immunophenotyping of human innate lymphoid cells | Methods in Molecular Biology | | 2019 | 337 | 1 | ||
| Peripheral innate lymphoid cells are increased in first line metastatic colorectal carcinoma patients: a negative correlation with th1 immune responses | Frontiers in Immunology | | 2019 | 332 | 159 | ||
| CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML | Blood Advances | | 2019 | 546 | 272 | ||
| ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells | Frontiers in Immunology | | 2017 | 319 | 195 | ||
| Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis | OncoImmunology | | 2017 | 406 | 0 | ||
| ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence | Journal of Clinical Investigation | | 2017 | 408 | 222 | ||
| Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis | Nature Communications | | 2017 | 689 | 241 |
